Classification: Pharmaceutical Intermediates
Cas NO.: 479633-63-1
Molecular Formula: C13H10ClN3O2S
Boiling Point: 505.3°C at 760 mmHg
Stability: null
Tofacitinib Citrate Intermediate. Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib citrate is marketed as Xeljanz and Jakvinus.